A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria

Clinical trial NCT05972629 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05972629
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Phenylketonuria

Start date: 2023-08-07
Primary completion: 2030-04-02
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.